Bosun Asset Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-24,889
Closed -$1.49M 125
2025
Q2
$1.49M Buy
24,889
+3,813
+18% +$209K 0.44% 47
2025
Q1
$1.11M Sell
21,076
-224
-1% -$12.6K 0.47% 52
2024
Q4
$1.17M Buy
21,300
+15,890
+294% +$836K 0.51% 62
2024
Q3
$272K Buy
+5,410
New +$250K 0.13% 160

Other funds holding IRMD

Bosun Asset Management's IRMD Position: Q3 2025 in Review

Bosun Asset Management sold out of iRadimed (IRMD) in Q3 2025, closing a stake of 24,889 shares — an estimated $1.49M sold.

Bosun Asset Management first reported a position in IRMD in Q3 2024 and held it in 4 quarters. The position peaked at $1.49M in Q2 2025. 185 funds tracked by Wall St. Rank hold IRMD as of Q3 2025.

  • Bosun Asset Management reported no remaining iRadimed position as of Q3 2025 after selling out during the quarter.
  • Bosun Asset Management sold 24,889 iRadimed shares in Q3 2025, an estimated $1.49M.
  • Bosun Asset Management first reported a position in iRadimed in Q3 2024 and held it in 4 quarters.
  • Bosun Asset Management's iRadimed position peaked at $1.49M in Q2 2025.
  • 185 funds tracked by Wall St. Rank held iRadimed as of Q3 2025.

Based on Bosun Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.